16 April 2024 in Frontiers in Immunology
Extracellular vesicles (EVs) are important cell-to-cell communication mediators. This paper focuses on the regulatory role of tumor-derived EVs on macrophages. It aims to investigate the causes of tumor progression and therapeutic directions. Tumor-derived EVs can cause macrophages to shift to M1 or M2 phenotypes. This indicates they can alter the M1/M2 cell ratio and have pro-tumor and anti-inflammatory effects. This paper discusses several key points: first, the factors that stimulate macrophage polarization and the cytokines released as a result; second, an overview of EVs and the methods used to isolate them; third, how EVs from various cancer cell sources, such as hepatocellular carcinoma, colorectal carcinoma, lung carcinoma, breast carcinoma, and glioblastoma cell sources carcinoma, promote tumor development by inducing M2 polarization in macrophages; and fourth, how EVs from breast carcinoma, pancreatic carcinoma, lungs carcinoma, and glioblastoma cell sources carcinoma also contribute to tumor development by promoting M2 polarization in macrophages. Modified or sourced EVs from breast, pancreatic, and colorectal cancer can repolarize M2 to M1 macrophages. This exhibits anti-tumor activities and offers novel approaches for tumor treatment. Therefore, we discovered that macrophage polarization to either M1 or M2 phenotypes can regulate tumor development. This is based on the description of altering macrophage phenotypes by vesicle contents.
24 October 2023 in Cellular and Molecular Neurobiology
29 September 2026 in Cellular and Molecular Neurobiology
In patients with inflammatory bowel disease (IBD), a high prevalence of comorbid major depressive disorder (MDD) has been observed. The two conditions also appear to show bidirectional clinical exacerbation. The classical gut-brain axis framework has not yet identified the specific molecular or cellular mediator that links peripheral intestinal inflammation to central mood dysfunction. Emerging evidence suggests that astrocytes might bridge this gap. In IBD, gut dysbiosis and peripheral inflammation propagate signals to the brain via humoral, neural, and endocrine pathways. These signals may promote astrocytic reactivity, possibly shifting the cells toward a reactive state with A1-like features. Such reactive astrocytes exhibit impaired glutamate clearance, compromised blood-brain barrier (BBB) integrity, disrupted energy support, diminished neurotrophic factor secretion, and sustained neuroinflammation. These deficits may lead to excitotoxicity, synaptic dysfunction, and destabilization of mood-regulating circuits, contributing to depressive-like behaviors. Astrocytes may also influence intestinal processes through the release of extracellular vesicles and interactions with enteric glial cells. This bidirectional communication could contribute to a potential self-reinforcing gut-brain-gut cycle. This review synthesises current evidence on astrocyte-mediated mechanisms in IBD and MDD comorbidity and outlines a framework for this bidirectional relationship. Graphical Abstract In IBD, gut dysbiosis and peripheral inflammation can propagate signals to the brain via humoral, neural, and endocrine pathways. These signals may promote astrocytic reactivity with complement component 3 (C3)-associated A1-like features, affecting glutamate homeostasis and energy support. These changes may contribute to altered synaptic and neuronal function relevant to depressive pathology, while efferent autonomic and hypothalamic-pituitary-adrenal (HPA)-axis signaling may further influence intestinal inflammation.
19 September 2024 in Journal of Traditional Chinese Medical Sciences